Skip to main content

and
  1. Article

    Open Access

    Comparative effectiveness of treatment with the first TNF antagonist in monotherapy, the first TNF antagonist plus one conventional synthetic disease-modifying antirheumatic drug, and the first TNF antagonist plus two or more conventional synthetic disease-modifying antirheumatic drugs in patients with rheumatoid arthritis

    Rheumatoid arthritis (RA) patients are treated with a mean of 3–4 conventional synthetic disease-modifying antirheumatic drugs (csDMARDs) with or without glucocorticoids (GCs), before the first biologic prescr...

    Blanca Hernández-Cruz, Esther Márquez-Saavedra in Arthritis Research & Therapy (2016)

  2. Article

    Open Access

    Rheumatoid arthritis response to treatment across IgG1 allotype – anti-TNF incompatibility: a case-only study

    We have hypothesized that incompatibility between the G1m genotype of the patient and the G1m1 and G1m17 allotypes carried by infliximab (INX) and adalimumab (ADM) could decrease the efficacy of these anti-tum...

    Ariana Montes, Eva Perez-Pampin, Federico Navarro-Sarabia in Arthritis Research & Therapy (2015)

  3. No Access

    Article

    A comparison of telephone and paper self-completed questionnaires of main patient-related outcome measures in patients with ankylosing spondylitis and psoriatic arthritis

    A cross-sectional study was performed to assess the correlation between telephone and self-administration of patient-related outcomes (PROs) used in the assessment of ankylosing spondylitis (AS) patients. Part...

    Rafael Ariza-Ariza, Blanca Hernández-Cruz in Rheumatology International (2013)

  4. No Access

    Article

    Low doses of etanercept can be effective in ankylosing spondylitis patients who achieve remission of the disease

    This study aims to explore the effectiveness of low dose of etanercept (ETN) in patients with ankylosing spondylitis (AS) who achieve a good control of their disease in daily clinical practice. This is a case ...

    Victoria Navarro-Compán, Virginia Moreira, Rafael Ariza-Ariza in Clinical Rheumatology (2011)

  5. Article

    Open Access

    DAS-28-based EULAR response and HAQ improvement in rheumatoid arthritis patients switching between TNF antagonists

    No definitive data are available regarding the value of switching to an alternative TNF antagonist in rheumatoid arthritis patients who fail to respond to the first one. The aim of this study was to evaluate t...

    Federico Navarro-Sarabia, Dolores Ruiz-Montesinos in BMC Musculoskeletal Disorders (2009)

  6. No Access

    Article

    Variables related to utility in patients with ankylosing spondylitis

    The objective of this study was to identify variables associated to the utility of the health states in patients with ankylosing spondylitis (AS). A cross-sectional study was performed in a tertiary care centr...

    Rafael Ariza-Ariza, Blanca Hernández-Cruz, Gloria López-Antequera in Clinical Rheumatology (2009)